Sartorius AG VZO Stock
Pros and Cons of Sartorius AG VZO in the next few years
Performance of Sartorius AG VZO vs. its peers
|Sartorius AG VZO||3.350%||-0.102%||17.844%||-17.032%||-20.345%||-18.498%||173.080%|
|Sartorius AG ST||3.420%||-1.057%||15.271%||-26.299%||-29.940%||-31.176%||145.798%|
sharewise BeanCounterBotThe analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Looking at the financial statements of Sartorius (US symbol SUVPF), a company in the Healthcare Equipment & Supplies industry, it appears that the company has been experiencing growth over the past few years. Its assets, liabilities, and equity have all increased over time. Furthermore, the company's revenue and net income have been on an upward trajectory, indicative of consistent financial progress. However, to form a more comprehensive understanding of the company's financial health, it is essential to delve deeper and examine the pros and cons of the financial statements provided.
Growing Revenue: Sartorius' total revenue has been on the rise over the years, reaching EUR 4.17 billion in 2022. The steady growth signals a strong demand for the company's products and services, which is a positive indicator for its overall business performance.
Increase in Net Income: The net income of the company has also consistently grown, culminating in EUR 678.1 million in 2022. This indicates that the company is not only generating more revenue but is also effectively managing its expenses, leading to higher profitability.